Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1134 entries
Sorted by: Best Match Show Resources per page
[Searching for an effective instruction method of clinical practice of student nurses].

Kango tenbo. The Japanese journal of nursing science

Matsumoto S, Watabe M, Tachi Y, Matsunaga M, Omura T.
PMID: 3849639
Kango Tenbo. 1985 Jun;10(7):723-9.

No abstract available.

Cite
Matsumoto S, Watabe M, Tachi Y, et al. [Searching for an effective instruction method of clinical practice of student nurses]. Kango Tenbo. 1985;10(7):723-9
Matsumoto, S., Watabe, M., Tachi, Y., Matsunaga, M., & Omura, T. (1985). [Searching for an effective instruction method of clinical practice of student nurses]. Kango tenbo. The Japanese journal of nursing science, 10(7), 723-9.
Matsumoto, S, et al. "[Searching for an effective instruction method of clinical practice of student nurses]." Kango tenbo. The Japanese journal of nursing science vol. 10,7 (1985): 723-9.
Matsumoto S, Watabe M, Tachi Y, Matsunaga M, Omura T. [Searching for an effective instruction method of clinical practice of student nurses]. Kango Tenbo. 1985 Jun;10(7):723-9. Japanese. PMID: 3849639.
Copy Download .nbib Format: NLM
A case of unusual histology of infantile lipoblastoma confirmed by PLAG1 rearrangement.

Surgical case reports

Shinkai T, Masumoto K, Ono K, Yano E, Kobayashi C, Fukushima T, Sumazaki R, Satomi K, Noguchi M.
PMID: 26943407
Surg Case Rep. 2015 Dec;1(1):42. doi: 10.1186/s40792-015-0042-4. Epub 2015 May 16.

Lipoblastoma, a relatively rare benign adipose neoplasm, predominantly affects children younger than 3 years of age. We herein report the case of a 7-month-old girl with an unusual myxomatous histology of lipoblastoma. A rapidly growing mass was detected in...

Cite
Shinkai T, Masumoto K, Ono K, et al. A case of unusual histology of infantile lipoblastoma confirmed by PLAG1 rearrangement. Surg Case Rep. 2015;1(1):42doi: 10.1186/s40792-015-0042-4.
Shinkai, T., Masumoto, K., Ono, K., Yano, E., Kobayashi, C., Fukushima, T., Sumazaki, R., Satomi, K., & Noguchi, M. (2015). A case of unusual histology of infantile lipoblastoma confirmed by PLAG1 rearrangement. Surgical case reports, 1(1), 42. https://doi.org/10.1186/s40792-015-0042-4
Shinkai, Toko, et al. "A case of unusual histology of infantile lipoblastoma confirmed by PLAG1 rearrangement." Surgical case reports vol. 1,1 (2015): 42. doi: https://doi.org/10.1186/s40792-015-0042-4
Shinkai T, Masumoto K, Ono K, Yano E, Kobayashi C, Fukushima T, Sumazaki R, Satomi K, Noguchi M. A case of unusual histology of infantile lipoblastoma confirmed by PLAG1 rearrangement. Surg Case Rep. 2015 Dec;1(1):42. doi: 10.1186/s40792-015-0042-4. Epub 2015 May 16. PMID: 26943407; PMCID: PMC4747941.
Copy Download .nbib Format: NLM
Usefulness of an Image Fusion Model Using Three-Dimensional CT and MRI with Indocyanine Green Fluorescence Endoscopy as a Multimodal Assistant System in Endoscopic Transsphenoidal Surgery.

International journal of endocrinology

Inoue A, Ohnishi T, Kohno S, Nishida N, Nakamura Y, Ohtsuka Y, Matsumoto S, Ohue S.
PMID: 26339240
Int J Endocrinol. 2015;2015:694273. doi: 10.1155/2015/694273. Epub 2015 Aug 03.

Purpose. We investigate the usefulness of multimodal assistant systems using a fusion model of preoperative three-dimensional (3D) computed tomography (CT) and magnetic resonance imaging (MRI) along with endoscopy with indocyanine green (ICG) fluorescence in establishing endoscopic endonasal transsphenoidal surgery...

Cite
Inoue A, Ohnishi T, Kohno S, et al. Usefulness of an Image Fusion Model Using Three-Dimensional CT and MRI with Indocyanine Green Fluorescence Endoscopy as a Multimodal Assistant System in Endoscopic Transsphenoidal Surgery. Int J Endocrinol. 2015;2015:694273doi: 10.1155/2015/694273.
Inoue, A., Ohnishi, T., Kohno, S., Nishida, N., Nakamura, Y., Ohtsuka, Y., Matsumoto, S., & Ohue, S. (2015). Usefulness of an Image Fusion Model Using Three-Dimensional CT and MRI with Indocyanine Green Fluorescence Endoscopy as a Multimodal Assistant System in Endoscopic Transsphenoidal Surgery. International journal of endocrinology, 2015694273. https://doi.org/10.1155/2015/694273
Inoue, Akihiro, et al. "Usefulness of an Image Fusion Model Using Three-Dimensional CT and MRI with Indocyanine Green Fluorescence Endoscopy as a Multimodal Assistant System in Endoscopic Transsphenoidal Surgery." International journal of endocrinology vol. 2015 (2015): 694273. doi: https://doi.org/10.1155/2015/694273
Inoue A, Ohnishi T, Kohno S, Nishida N, Nakamura Y, Ohtsuka Y, Matsumoto S, Ohue S. Usefulness of an Image Fusion Model Using Three-Dimensional CT and MRI with Indocyanine Green Fluorescence Endoscopy as a Multimodal Assistant System in Endoscopic Transsphenoidal Surgery. Int J Endocrinol. 2015;2015:694273. doi: 10.1155/2015/694273. Epub 2015 Aug 03. PMID: 26339240; PMCID: PMC4539066.
Copy Download .nbib Format: NLM
Monitoring the Discontinuous Dodecamer-Icosamer Transition of a Calix[4]arene-Derived Surfactant by Time-Resolved Small-Angle X-ray Scattering.

Angewandte Chemie (International ed. in English)

Takahashi R, Matsumoto S, Fujii S, Narayanan T, Sakurai K.
PMID: 28481461
Angew Chem Int Ed Engl. 2017 Jun 06;56(24):6734-6738. doi: 10.1002/anie.201702260. Epub 2017 May 08.

Calix[4]arene-derived surfactants form monodisperse micelles with a well-defined aggregation number (N

Cite
Takahashi R, Matsumoto S, Fujii S, et al. Monitoring the Discontinuous Dodecamer-Icosamer Transition of a Calix[4]arene-Derived Surfactant by Time-Resolved Small-Angle X-ray Scattering. Angew Chem Int Ed Engl. 2017;56(24):6734-6738doi: 10.1002/anie.201702260.
Takahashi, R., Matsumoto, S., Fujii, S., Narayanan, T., & Sakurai, K. (2017). Monitoring the Discontinuous Dodecamer-Icosamer Transition of a Calix[4]arene-Derived Surfactant by Time-Resolved Small-Angle X-ray Scattering. Angewandte Chemie (International ed. in English), 56(24), 6734-6738. https://doi.org/10.1002/anie.201702260
Takahashi, Rintaro, et al. "Monitoring the Discontinuous Dodecamer-Icosamer Transition of a Calix[4]arene-Derived Surfactant by Time-Resolved Small-Angle X-ray Scattering." Angewandte Chemie (International ed. in English) vol. 56,24 (2017): 6734-6738. doi: https://doi.org/10.1002/anie.201702260
Takahashi R, Matsumoto S, Fujii S, Narayanan T, Sakurai K. Monitoring the Discontinuous Dodecamer-Icosamer Transition of a Calix[4]arene-Derived Surfactant by Time-Resolved Small-Angle X-ray Scattering. Angew Chem Int Ed Engl. 2017 Jun 06;56(24):6734-6738. doi: 10.1002/anie.201702260. Epub 2017 May 08. PMID: 28481461.
Copy Download .nbib Format: NLM
Maintenance of Mouse, Rat, and Pig Pancreatic Islet Functions by Coculture with Human Islet-Derived Fibroblasts.

Cell transplantation

Miki A, Narushima M, Okitsu T, Takeno Y, Soto-Gutierrez A, Rivas-Carrillo JD, Navarro-Alvarez N, Chen Y, Tanaka K, Noguchi H, Matsumoto S, Kohara M, Lakey JRT, Kobayashi E, Tanaka N, Kobayashi N.
PMID: 28863744
Cell Transplant. 2006 Apr;15(4):325-334. doi: 10.3727/000000006783981882.

Development of an efficient preculture system of islets is ideal. Toward that goal, we constructed a human pancreatic islet-derived fibroblast cell line MNNK-1 for a source as a coculture system for freshly isolated islets to maintain islet functions. Human...

Cite
Miki A, Narushima M, Okitsu T, et al. Maintenance of Mouse, Rat, and Pig Pancreatic Islet Functions by Coculture with Human Islet-Derived Fibroblasts. Cell Transplant. 2006;15(4):325-334doi: 10.3727/000000006783981882.
Miki, A., Narushima, M., Okitsu, T., Takeno, Y., Soto-Gutierrez, A., Rivas-Carrillo, J. D., Navarro-Alvarez, N., Chen, Y., Tanaka, K., Noguchi, H., Matsumoto, S., Kohara, M., Lakey, J. R. T., Kobayashi, E., Tanaka, N., & Kobayashi, N. (2006). Maintenance of Mouse, Rat, and Pig Pancreatic Islet Functions by Coculture with Human Islet-Derived Fibroblasts. Cell transplantation, 15(4), 325-334. https://doi.org/10.3727/000000006783981882
Miki, Atsushi, et al. "Maintenance of Mouse, Rat, and Pig Pancreatic Islet Functions by Coculture with Human Islet-Derived Fibroblasts." Cell transplantation vol. 15,4 (2006): 325-334. doi: https://doi.org/10.3727/000000006783981882
Miki A, Narushima M, Okitsu T, Takeno Y, Soto-Gutierrez A, Rivas-Carrillo JD, Navarro-Alvarez N, Chen Y, Tanaka K, Noguchi H, Matsumoto S, Kohara M, Lakey JRT, Kobayashi E, Tanaka N, Kobayashi N. Maintenance of Mouse, Rat, and Pig Pancreatic Islet Functions by Coculture with Human Islet-Derived Fibroblasts. Cell Transplant. 2006 Apr;15(4):325-334. doi: 10.3727/000000006783981882. PMID: 28863744.
Copy Download .nbib Format: NLM
Plasma exchange and chelator therapy rescues acute liver failure in Wilson disease without liver transplantation.

Hepatology research : the official journal of the Japan Society of Hepatology

Kido J, Matsumoto S, Momosaki K, Sakamoto R, Mitsubuchi H, Inomata Y, Endo F, Nakamura K.
PMID: 27007780
Hepatol Res. 2017 Mar;47(4):359-363. doi: 10.1111/hepr.12711. Epub 2016 May 28.

AIM: Wilson disease (WD) in patients with a New Wilson Index (NWI) score ≥ 11 is fatal, and these patients are good candidates for liver transplantation (LT). However, plasma exchange and chelator therapy are indispensable and effective even for...

Cite
Kido J, Matsumoto S, Momosaki K, et al. Plasma exchange and chelator therapy rescues acute liver failure in Wilson disease without liver transplantation. Hepatol Res. 2016;47(4):359-363doi: 10.1111/hepr.12711.
Kido, J., Matsumoto, S., Momosaki, K., Sakamoto, R., Mitsubuchi, H., Inomata, Y., Endo, F., & Nakamura, K. (2017). Plasma exchange and chelator therapy rescues acute liver failure in Wilson disease without liver transplantation. Hepatology research : the official journal of the Japan Society of Hepatology, 47(4), 359-363. https://doi.org/10.1111/hepr.12711
Kido, Jun, et al. "Plasma exchange and chelator therapy rescues acute liver failure in Wilson disease without liver transplantation." Hepatology research : the official journal of the Japan Society of Hepatology vol. 47,4 (2017): 359-363. doi: https://doi.org/10.1111/hepr.12711
Kido J, Matsumoto S, Momosaki K, Sakamoto R, Mitsubuchi H, Inomata Y, Endo F, Nakamura K. Plasma exchange and chelator therapy rescues acute liver failure in Wilson disease without liver transplantation. Hepatol Res. 2017 Mar;47(4):359-363. doi: 10.1111/hepr.12711. Epub 2016 May 28. PMID: 27007780.
Copy Download .nbib Format: NLM
Barley NARROW LEAFED DWARF1 encoding a WUSCHEL-RELATED HOMEOBOX 3 (WOX3) regulates the marginal development of lateral organs.

Breeding science

Yoshikawa T, Tanaka SY, Masumoto Y, Nobori N, Ishii H, Hibara K, Itoh J, Tanisaka T, Taketa S.
PMID: 27436952
Breed Sci. 2016 Jun;66(3):416-24. doi: 10.1270/jsbbs.16019. Epub 2016 May 20.

Barley (Hordeum vulgare L.) is the fourth most-produced cereal in the world and is mainly utilized as animal feed and malts. Recently barley attracts considerable attentions as healthy food rich in dietary fiber. However, limited knowledge is available about...

Cite
Yoshikawa T, Tanaka SY, Masumoto Y, et al. Barley NARROW LEAFED DWARF1 encoding a WUSCHEL-RELATED HOMEOBOX 3 (WOX3) regulates the marginal development of lateral organs. Breed Sci. 2016;66(3):416-24doi: 10.1270/jsbbs.16019.
Yoshikawa, T., Tanaka, S. Y., Masumoto, Y., Nobori, N., Ishii, H., Hibara, K., Itoh, J., Tanisaka, T., & Taketa, S. (2016). Barley NARROW LEAFED DWARF1 encoding a WUSCHEL-RELATED HOMEOBOX 3 (WOX3) regulates the marginal development of lateral organs. Breeding science, 66(3), 416-24. https://doi.org/10.1270/jsbbs.16019
Yoshikawa, Takanori, et al. "Barley NARROW LEAFED DWARF1 encoding a WUSCHEL-RELATED HOMEOBOX 3 (WOX3) regulates the marginal development of lateral organs." Breeding science vol. 66,3 (2016): 416-24. doi: https://doi.org/10.1270/jsbbs.16019
Yoshikawa T, Tanaka SY, Masumoto Y, Nobori N, Ishii H, Hibara K, Itoh J, Tanisaka T, Taketa S. Barley NARROW LEAFED DWARF1 encoding a WUSCHEL-RELATED HOMEOBOX 3 (WOX3) regulates the marginal development of lateral organs. Breed Sci. 2016 Jun;66(3):416-24. doi: 10.1270/jsbbs.16019. Epub 2016 May 20. PMID: 27436952; PMCID: PMC4902465.
Copy Download .nbib Format: NLM
Examination of the clinical efficacy of eribulin and trastuzumab in HER2-positive recurrent breast cancer.

Molecular and clinical oncology

Kiba T, Morii N, Takahashi H, Ozaki S, Atsumi M, Masumoto F, Shitakubo Y, Yamashiro H.
PMID: 26870356
Mol Clin Oncol. 2016 Jan;4(1):47-50. doi: 10.3892/mco.2015.668. Epub 2015 Nov 05.

There are limited studies reported that describe the efficacy of eribulin and trastuzumab in the treatment of recurrent breast cancer. The present study examined the therapeutic efficacy of eribulin and trastuzumab in the treatment of recurrent breast cancer. Between...

Cite
Kiba T, Morii N, Takahashi H, et al. Examination of the clinical efficacy of eribulin and trastuzumab in HER2-positive recurrent breast cancer. Mol Clin Oncol. 2015;4(1):47-50doi: 10.3892/mco.2015.668.
Kiba, T., Morii, N., Takahashi, H., Ozaki, S., Atsumi, M., Masumoto, F., Shitakubo, Y., & Yamashiro, H. (2016). Examination of the clinical efficacy of eribulin and trastuzumab in HER2-positive recurrent breast cancer. Molecular and clinical oncology, 4(1), 47-50. https://doi.org/10.3892/mco.2015.668
Kiba, Takayoshi, et al. "Examination of the clinical efficacy of eribulin and trastuzumab in HER2-positive recurrent breast cancer." Molecular and clinical oncology vol. 4,1 (2016): 47-50. doi: https://doi.org/10.3892/mco.2015.668
Kiba T, Morii N, Takahashi H, Ozaki S, Atsumi M, Masumoto F, Shitakubo Y, Yamashiro H. Examination of the clinical efficacy of eribulin and trastuzumab in HER2-positive recurrent breast cancer. Mol Clin Oncol. 2016 Jan;4(1):47-50. doi: 10.3892/mco.2015.668. Epub 2015 Nov 05. PMID: 26870356; PMCID: PMC4727054.
Copy Download .nbib Format: NLM
Preface.

Progress in brain research

Masamoto K, Hirase H, Yamada K.
PMID: 27130421
Prog Brain Res. 2016;225:xv. doi: 10.1016/S0079-6123(16)30022-X.

No abstract available.

Cite
Masamoto K, Hirase H, Yamada K. Preface. Prog Brain Res. 2016;225:xvdoi: 10.1016/S0079-6123(16)30022-X.
Masamoto, K., Hirase, H., & Yamada, K. (2016). Preface. Progress in brain research, 225xv. https://doi.org/10.1016/S0079-6123(16)30022-X
Masamoto, Kazuto, et al. "Preface." Progress in brain research vol. 225 (2016): xv. doi: https://doi.org/10.1016/S0079-6123(16)30022-X
Masamoto K, Hirase H, Yamada K. Preface. Prog Brain Res. 2016;225:xv. doi: 10.1016/S0079-6123(16)30022-X. PMID: 27130421.
Copy Download .nbib Format: NLM
Effect of amifostine, a radiation-protecting drug, on oxygen concentration in tissue measured by EPR oximetry and imaging.

Journal of clinical biochemistry and nutrition

Ueno M, Matsumoto S, Matsumoto A, Manda S, Nakanishi I, Matsumoto KI, Mitchell JB, Krishna MC, Anzai K.
PMID: 28584395
J Clin Biochem Nutr. 2017 May;60(3):151-155. doi: 10.3164/jcbn.15-130. Epub 2017 Mar 25.

Effect of amifostine, a radiation-protecting drug, on muscle tissue partial pressure of oxygen was investigated by electron paramagnetic resonance spectroscopy and imaging. When amifostine was administered intraperitoneally or intravenously to mice, the linewidth of the electron paramagnetic resonance spectra...

Cite
Ueno M, Matsumoto S, Matsumoto A, et al. Effect of amifostine, a radiation-protecting drug, on oxygen concentration in tissue measured by EPR oximetry and imaging. J Clin Biochem Nutr. 2017;60(3):151-155doi: 10.3164/jcbn.15-130.
Ueno, M., Matsumoto, S., Matsumoto, A., Manda, S., Nakanishi, I., Matsumoto, K. I., Mitchell, J. B., Krishna, M. C., & Anzai, K. (2017). Effect of amifostine, a radiation-protecting drug, on oxygen concentration in tissue measured by EPR oximetry and imaging. Journal of clinical biochemistry and nutrition, 60(3), 151-155. https://doi.org/10.3164/jcbn.15-130
Ueno, Megumi, et al. "Effect of amifostine, a radiation-protecting drug, on oxygen concentration in tissue measured by EPR oximetry and imaging." Journal of clinical biochemistry and nutrition vol. 60,3 (2017): 151-155. doi: https://doi.org/10.3164/jcbn.15-130
Ueno M, Matsumoto S, Matsumoto A, Manda S, Nakanishi I, Matsumoto KI, Mitchell JB, Krishna MC, Anzai K. Effect of amifostine, a radiation-protecting drug, on oxygen concentration in tissue measured by EPR oximetry and imaging. J Clin Biochem Nutr. 2017 May;60(3):151-155. doi: 10.3164/jcbn.15-130. Epub 2017 Mar 25. PMID: 28584395; PMCID: PMC5453015.
Copy Download .nbib Format: NLM
Pathological complete response rate in hormone receptor-negative breast cancer treated with neoadjuvant FEC, followed by weekly paclitaxel administration: A retrospective study and review of the literature.

Oncology letters

Kiba T, Morii N, Takahashi H, Ozaki S, Atsumi M, Masumoto F, Yamashiro H.
PMID: 27123064
Oncol Lett. 2016 May;11(5):3064-3070. doi: 10.3892/ol.2016.4334. Epub 2016 Mar 16.

While tumor size, the presence of inflammatory carcinoma and lymph node involvement are the main prognostic factors of women with locally advanced breast cancer, the prognostic value of the estrogen receptor, progesterone receptor and human epidermal growth factor receptor...

Cite
Kiba T, Morii N, Takahashi H, et al. Pathological complete response rate in hormone receptor-negative breast cancer treated with neoadjuvant FEC, followed by weekly paclitaxel administration: A retrospective study and review of the literature. Oncol Lett. 2016;11(5):3064-3070doi: 10.3892/ol.2016.4334.
Kiba, T., Morii, N., Takahashi, H., Ozaki, S., Atsumi, M., Masumoto, F., & Yamashiro, H. (2016). Pathological complete response rate in hormone receptor-negative breast cancer treated with neoadjuvant FEC, followed by weekly paclitaxel administration: A retrospective study and review of the literature. Oncology letters, 11(5), 3064-3070. https://doi.org/10.3892/ol.2016.4334
Kiba, Takayoshi, et al. "Pathological complete response rate in hormone receptor-negative breast cancer treated with neoadjuvant FEC, followed by weekly paclitaxel administration: A retrospective study and review of the literature." Oncology letters vol. 11,5 (2016): 3064-3070. doi: https://doi.org/10.3892/ol.2016.4334
Kiba T, Morii N, Takahashi H, Ozaki S, Atsumi M, Masumoto F, Yamashiro H. Pathological complete response rate in hormone receptor-negative breast cancer treated with neoadjuvant FEC, followed by weekly paclitaxel administration: A retrospective study and review of the literature. Oncol Lett. 2016 May;11(5):3064-3070. doi: 10.3892/ol.2016.4334. Epub 2016 Mar 16. PMID: 27123064; PMCID: PMC4841046.
Copy Download .nbib Format: NLM
Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits.

Oncotarget

Yoshida T, Ri M, Kanamori T, Aoki S, Ashour R, Kinoshita S, Narita T, Totani H, Masaki A, Ito A, Kusumoto S, Ishida T, Komatsu H, Kitahata S, Chiba T, Ichikawa S, Iida S.
PMID: 29515784
Oncotarget. 2018 Jan 11;9(11):9975-9991. doi: 10.18632/oncotarget.24160. eCollection 2018 Feb 09.

Proteasome inhibitors (PI), mainly targeting the β5 subunit of the 20S proteasome, are widely used in the treatment of multiple myeloma (MM). However, PI resistance remains an unresolved problem in the therapy of relapsed and refractory MM. To develop...

Cite
Yoshida T, Ri M, Kanamori T, et al. Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits. Oncotarget. 2018;9(11):9975-9991doi: 10.18632/oncotarget.24160.
Yoshida, T., Ri, M., Kanamori, T., Aoki, S., Ashour, R., Kinoshita, S., Narita, T., Totani, H., Masaki, A., Ito, A., Kusumoto, S., Ishida, T., Komatsu, H., Kitahata, S., Chiba, T., Ichikawa, S., & Iida, S. (2018). Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits. Oncotarget, 9(11), 9975-9991. https://doi.org/10.18632/oncotarget.24160
Yoshida, Takashi, et al. "Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits." Oncotarget vol. 9,11 (2018): 9975-9991. doi: https://doi.org/10.18632/oncotarget.24160
Yoshida T, Ri M, Kanamori T, Aoki S, Ashour R, Kinoshita S, Narita T, Totani H, Masaki A, Ito A, Kusumoto S, Ishida T, Komatsu H, Kitahata S, Chiba T, Ichikawa S, Iida S. Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits. Oncotarget. 2018 Jan 11;9(11):9975-9991. doi: 10.18632/oncotarget.24160. eCollection 2018 Feb 09. PMID: 29515784; PMCID: PMC5839415.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1134 entries